Press Release: the Baldwin Group Announces Second Quarter 2026 Results

Dow Jones
07/31

-- Second Quarter Total Revenue Growth of 30% to $492.9 Million --

-- Second Quarter Net Loss of $56.0 Million; Adjusted EBITDA(1) Growth of 37% to $116.7 Million --

-- Second Quarter Diluted Loss Per Share of $0.42; Adjusted Diluted EPS(2) of $0.48 --

-- Second Quarter Net Loss Margin of 11%; Adjusted EBITDA Margin(1) of 24% --

-- Second Quarter Net Cash Provided by Operating Activities of $45.6 Million; Adjusted Free Cash Flow(3) Increased 437% to $46.4 Million --

-- Year-to-Date Net Cash Provided by Operating Activities of $39.5 Million; Adjusted Free Cash Flow Increased 34% to $46.2 Million --

TAMPA, Fla.--(BUSINESS WIRE)--July 30, 2026-- 

The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. ("Baldwin" or the "Company") (NASDAQ: BWIN), an independent insurance distribution firm delivering tailored insurance solutions to a wide range of personal and commercial clients, today announced its results for the second quarter ended June 30, 2026.

SECOND QUARTER 2026 HIGHLIGHTS

   --  Total revenue increased 30% year-over-year to $492.9 million 
 
   --  Organic revenue growth(4) of 2% year-over-year 
 
   --  CAC Group total revenue growth(5) of 23% year-over-year 
 
   --  GAAP net loss of $56.0 million and GAAP diluted loss per share of 
      $0.42 
 
   --  Adjusted net income(2) of $68.5 million 
 
   --  Adjusted diluted EPS increased 14% year-over-year to $0.48 
 
   --  Adjusted EBITDA grew 37% to $116.7 million 
 
   --  Net loss margin of 11% 
 
   --  Adjusted EBITDA margin of 23.7%, a 110 basis point expansion compared 
      to 22.6% in the prior-year period 
 
   --  Net cash provided by operating activities of $45.6 million 
 
   --  Adjusted free cash flow increased 437% year-over-year to $46.4 million 
 

"We are thrilled with our momentum as reflected in our strong second quarter results. Total revenue grew 30% to $492.9 million, adjusted EBITDA grew 37% to $116.7 million, and adjusted free cash flow increased 437% to $46.4 million," said Trevor Baldwin, Chief Executive Officer of The Baldwin Group. "As we previously highlighted, we have largely lapped the idiosyncratic, one-time headwinds that we believe will transition into tailwinds for our business in the back half of 2026. When combined with the strong contribution from our recent partnerships, we continue to win market share at an outsized rate, evidenced by sales velocity of 30% in our combined IAS business and normalized organic growth of 8%. This is a testament to the depth of expertise, value delivered to clients, and commitment from our dedicated colleagues."

Baldwin added, "We remain excited for the opportunities we have ahead of us and what we can achieve in the coming year for shareholders, clients and colleagues."

LIQUIDITY AND CAPITAL RESOURCES

As of June 30, 2026, cash and cash equivalents were $184.5 million and the Company had $259.4 million of borrowing capacity under its revolving credit facility.

SIX MONTHS 2026 RESULTS

   --  Revenue increased 29% year-over-year to $1.0 billion 
 
   --  Organic revenue growth of 2% year-over-year 
 
   --  CAC Group total revenue growth of 25% year-over-year 
 
   --  GAAP net loss of $57.9 million and GAAP diluted loss per share of 
      $0.39 
 
   --  Adjusted net income of $157.8 million 
 
   --  Adjusted diluted EPS grew 5% year-over-year to $1.11 
 
   --  Adjusted EBITDA grew 27% year-over-year to $254.0 million 
 
   --  Net loss margin of 6% 
 
   --  Adjusted EBITDA margin was 24.8% compared to 25.2% in the prior-year 
      period 
 
   --  Net cash provided by operating activities of $39.5 million 
 
   --  Adjusted free cash flow increased 34% year-over-year to $46.2 million 
 

WEBCAST AND CONFERENCE CALL INFORMATION

Baldwin will host a live audio webcast today at 5:00 PM Eastern Time to discuss the Company's second quarter 2026 performance, including management's perspectives on the business. The live audio webcast will be accessible via Baldwin's investor relations website at ir.baldwin.com and a replay of the webcast will be available at ir.baldwin.com for approximately one year.

ABOUT THE BALDWIN GROUP

The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. ("Baldwin") (NASDAQ: BWIN) and its affiliates, is an independent insurance distribution firm providing indispensable expertise and insights that strive to give our clients the confidence to pursue their purpose, passion and dreams. As a team of dedicated entrepreneurs and insurance professionals, we have come together to help protect the possible for our clients. We do this by delivering bespoke client solutions, services, and innovation through our comprehensive and tailored approach to risk management, insurance, and employee benefits. We support our clients, colleagues, insurance company partners, and communities through the deployment of vanguard resources and capital to drive our organic and inorganic growth. The Baldwin Group proudly represents more than three million clients across the United States and internationally. For more information, please visit www.baldwin.com.

FOOTNOTES

 
(1)   Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures. 
      Reconciliation of adjusted EBITDA and adjusted EBITDA margin to net 
      income (loss), the most directly comparable GAAP financial measure, is 
      set forth in the reconciliation table accompanying this release. 
 
(2)   Adjusted net income and adjusted diluted EPS are non-GAAP measures. 
      Reconciliation of adjusted net income to net income attributable to 
      Baldwin and reconciliation of adjusted diluted EPS to diluted earnings 
      (loss) per share, the most directly comparable GAAP financial measures, 
      is set forth in the reconciliation table accompanying this release. 
 
(3)   Adjusted free cash flow is a non-GAAP measure. Reconciliation of 
      adjusted free cash flow to net cash provided by (used in) operating 
      activities, the most directly comparable GAAP financial measure, is set 
      forth in the reconciliation table accompanying this release. 
 
(4)   Organic revenue for the three and six months ended June 30, 2025 used to 
      calculate organic revenue growth for the three and six months ended June 
      30, 2026 was $376.3 million and $786.8 million, respectively, which is 
      adjusted to exclude commissions and fees from divestitures that occurred 
      during 2025. Organic revenue is also adjusted to exclude the first 12 
      months of commissions and fees generated from new partners during the 
      three and six months ended June 30, 2026. Organic revenue and organic 
      revenue growth are non-GAAP measures. Reconciliation of organic revenue 
      and organic revenue growth to commissions and fees, the most directly 
      comparable GAAP financial measure, is set forth in the reconciliation 
      table accompanying this release. 
 
(5)   CAC Group total revenue growth is calculated as standalone CAC Group 
      GAAP revenue for the three and six months ended June 30, 2026 compared 
      to CAC Group GAAP revenue for the three and six months ended June 30, 
      2025. 
 

NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release may contain various "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Baldwin's expectations or beliefs concerning future events. Forward-looking statements are statements other than historical facts and may include statements that address Baldwin's future operating, financial or business performance or Baldwin's strategies or expectations. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "projects," "potential," "outlook" or "continue," or the negative of these terms or other comparable terminology. Forward-looking statements are based on management's current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.

Factors that could cause actual results or performance to differ from the expectations expressed or implied in such forward-looking statements include, but are not limited to, those described under the caption "Risk Factors" in Baldwin's Annual Report on Form 10-K for the year ended December 31, 2025 and in Baldwin's other filings with the SEC, which are available free of charge on the SEC's website at: www.sec.gov, including those risks and other factors relevant to Baldwin's business, financial condition and results of operations. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Baldwin or to persons acting on Baldwin's behalf are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Baldwin does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law.

 
                 THE BALDWIN INSURANCE GROUP, INC. 
 Condensed Consolidated Statements of Comprehensive Income (Loss) 
                            (Unaudited) 
 
                     For the Three Months     For the Six Months 
                        Ended June 30,          Ended June 30, 
                     --------------------  ------------------------ 
(in thousands, 
except per share 
data)                  2026       2025        2026         2025 
                     ---------  ---------  -----------  ----------- 
Revenues: 
   Commissions and 
    fees             $488,789   $376,249   $1,017,650   $786,780 
   Investment 
    income              4,150      2,562        7,524      5,436 
                      -------    -------    ---------    ------- 
      Total 
       revenues       492,939    378,811    1,025,174    792,216 
 
Operating 
expenses: 
   Colleague 
    compensation 
    and benefits      264,323    195,471      547,935    393,491 
   Outside 
    commissions        71,798     73,586      138,477    139,409 
   Other operating 
    expenses           94,058     56,119      318,221    114,138 
   Amortization 
    expense            56,027     26,010      111,074     51,892 
   Change in fair 
    value of 
    contingent 
    consideration      12,303     (1,957)      14,272      6,104 
   Depreciation 
    expense             2,773      1,642        4,804      3,225 
                      -------    -------    ---------    ------- 
      Total 
       operating 
       expenses       501,282    350,871    1,134,783    708,259 
 
Operating income 
 (loss)                (8,343)    27,940     (109,609)    83,957 
 
Other income 
(expense): 
   Interest 
    expense, net      (45,666)   (31,320)     (84,566)   (61,296) 
   Gain (loss) on 
    divestitures           --     (1,111)          --        290 
   Loss on 
    extinguishment 
    and 
    modification of 
    debt                 (129)        --       (7,538)    (2,394) 
   Other income 
    (expense), net     (2,423)        35       (1,776)      (115) 
                      -------    -------    ---------    ------- 
      Total other 
       expense, 
       net            (48,218)   (32,396)     (93,880)   (63,515) 
                      -------    -------    ---------    ------- 
 
Income (loss) 
 before income 
 taxes and share of 
 net earnings of 
 equity method 
 investee             (56,561)    (4,456)    (203,489)    20,442 
   Share of net 
    earnings of 
    equity method 
    investee              664         --        1,175         -- 
                      -------    -------    ---------    ------- 
Income (loss) 
 before income 
 taxes                (55,897)    (4,456)    (202,314)    20,442 
   Less: income tax 
    expense 
    (benefit)              84        685     (144,437)       685 
                      -------    -------    ---------    ------- 
Net income (loss)     (55,981)    (5,141)     (57,877)    19,757 
   Less: net income 
    (loss) 
    attributable to 
    noncontrolling 
    interests         (16,986)    (1,977)     (21,223)     8,982 
                      -------    -------    ---------    ------- 
Net income (loss) 
 attributable to 
 Baldwin             $(38,995)  $ (3,164)  $  (36,654)  $ 10,775 
                      =======    =======    =========    ======= 
 
Basic earnings 
 (loss) per share    $  (0.42)  $  (0.05)  $    (0.39)  $   0.16 
Diluted earnings 
 (loss) per share    $  (0.42)  $  (0.05)  $    (0.39)  $   0.15 
Weighted-average 
 shares of Class A 
 common stock 
 outstanding - 
 basic                 92,761     68,010       93,278     67,045 
Weighted-average 
 shares of Class A 
 common stock 
 outstanding - 
 diluted               92,761     68,010       93,278     70,393 
 
Net income (loss)    $(55,981)  $ (5,141)  $  (57,877)  $ 19,757 
   Other 
    comprehensive 
    income              3,343         --        6,635         -- 
                      -------    -------    ---------    ------- 
Comprehensive 
 income (loss)        (52,638)    (5,141)     (51,242)    19,757 
   Less: 
    comprehensive 
    income (loss) 
    attributable to 
    noncontrolling 
    interests         (15,932)    (1,977)     (19,123)     8,982 
                      -------    -------    ---------    ------- 
Comprehensive 
 income (loss) 
 attributable to 
 Baldwin             $(36,706)  $ (3,164)  $  (32,119)  $ 10,775 
                      =======    =======    =========    ======= 
 
 
                   THE BALDWIN INSURANCE GROUP, INC. 
                 Condensed Consolidated Balance Sheets 
                              (Unaudited) 
 
(in thousands, except share and 
per share data)                    June 30, 2026     December 31, 2025 
                                  ---------------  --------------------- 
            Assets 
Current assets: 
   Cash and cash equivalents       $     184,499    $         123,669 
   Fiduciary cash                        426,189              223,228 
   Assumed premiums, commissions 
    and fees receivable, net             433,617              342,136 
   Fiduciary receivables                 782,194              497,035 
   Prepaid expenses and other 
    current assets                        19,592               13,650 
                                      ----------       -------------- 
      Total current assets             1,846,091            1,199,718 
Property and equipment, net               33,377               22,502 
Right-of-use assets                       81,552               61,976 
Other assets                             111,257               82,419 
Intangible assets, net                 1,450,040              978,434 
Goodwill                               2,652,407            1,517,171 
                                      ----------       -------------- 
   Total assets                    $   6,174,724    $       3,862,220 
                                      ==========       ============== 
 Liabilities, Mezzanine Equity 
   and Stockholders' Equity 
Current liabilities: 
   Fiduciary liabilities           $   1,208,383    $         720,263 
   Commissions payable                    97,040               50,933 
   Accrued expenses and other 
    current liabilities                  294,241              252,560 
   Current portion of contingent 
    earnout liabilities                  120,901                9,004 
                                      ----------       -------------- 
      Total current liabilities        1,720,565            1,032,760 
Revolving line of credit                 302,000              107,000 
Long-term debt, less current 
 portion                               2,150,725            1,566,122 
Contingent earnout liabilities, 
 less current portion                    225,923               14,289 
Operating lease liabilities, 
 less current portion                     75,128               57,651 
Tax Receivable Agreement 
liabilities                              144,570                   -- 
Deferred tax liabilities                   4,650                   -- 
Other liabilities                        129,376                   -- 
                                      ----------       -------------- 
   Total liabilities                   4,752,937            2,777,822 
                                      ----------       -------------- 
Commitments and contingencies 
Mezzanine equity: 
   Redeemable noncontrolling 
    interest                                 614                  519 
Stockholders' equity: 
   Class A common stock, par 
    value $0.01 per share, 
    300,000,000 shares 
    authorized; 96,368,518 and 
    71,779,608 shares issued and 
    outstanding at June 30, 2026 
    and December 31, 2025, 
    respectively                             964                  718 
   Class B common stock, par 
    value $0.0001 per share, 
    100,000,000 shares 
    authorized; 43,059,762 and 
    46,703,818 shares issued and 
    outstanding at June 30, 2026 
    and December 31, 2025, 
    respectively                               4                    5 
   Additional paid-in capital          1,246,901              844,236 
   Accumulated deficit                  (368,468)            (245,236) 
   Accumulated other 
    comprehensive income                   5,027                  492 
                                      ----------       -------------- 
      Total stockholders' equity 
       attributable to Baldwin           884,428              600,215 
   Noncontrolling interest               536,745              483,664 
                                      ----------       -------------- 
      Total stockholders' equity       1,421,173            1,083,879 
                                      ----------       -------------- 
         Total liabilities, 
          mezzanine equity and 
          stockholders' equity     $   6,174,724    $       3,862,220 
                                      ==========       ============== 
 
 
                 THE BALDWIN INSURANCE GROUP, INC. 
          Condensed Consolidated Statements of Cash Flows 
                            (Unaudited) 
 
                                               For the Six Months 
                                                 Ended June 30, 
                                            ------------------------ 
(in thousands)                                 2026         2025 
                                            ----------  ------------ 
Cash flows from operating activities: 
   Net income (loss)                        $ (57,877)  $  19,757 
   Adjustments to reconcile net income 
   (loss) to net cash provided by (used 
   in) operating activities: 
      Depreciation and amortization           115,878      55,117 
      Change in fair value of contingent 
       consideration                           14,272       6,104 
      Share-based compensation expense         33,519      29,755 
      Deferred taxes                          (14,873)         -- 
      Payment of contingent earnout 
       consideration in excess of purchase 
       price accrual                           (6,739)    (85,090) 
      Gain on divestitures                         --        (290) 
      Amortization of deferred financing 
       costs                                    8,633       2,843 
      Other operating activity                 (2,602)        766 
   Changes in operating assets and 
   liabilities: 
      Assumed premiums, commissions and 
       fees receivable, net                   (46,138)    (53,896) 
      Prepaid expenses and other current 
       assets                                  (6,866)     (4,916) 
      Right-of-use assets                      13,531       7,950 
      Accounts payable, accrued expenses 
       and other current liabilities           (3,731)    (19,727) 
      Colleague earnout incentives                 --     (31,824) 
      Operating lease liabilities              (7,521)     (7,253) 
                                             --------    -------- 
         Net cash provided by (used in) 
          operating activities                 39,486     (80,704) 
                                             --------    -------- 
Cash flows from investing activities: 
   Cash consideration paid for business 
    combinations, net of cash received       (447,503)    (11,699) 
   Capital expenditures                       (27,848)    (20,310) 
   Deferred payments for business 
    combinations                              (25,000)         -- 
   Cash consideration paid for asset 
    acquisitions                              (12,052)       (460) 
   Investments in and loans for business 
    ventures                                   (8,465)    (15,633) 
   Proceeds from divestitures, net of cash 
    transferred                                    --       1,901 
                                             --------    -------- 
      Net cash used in investing 
       activities                            (520,868)    (46,201) 
                                             --------    -------- 
Cash flows from financing activities: 
   Change in fiduciary receivables and 
    liabilities, net                           98,968      55,283 
   Repurchase of common stock                (126,833)         -- 
   Proceeds from revolving line of credit     371,000     121,000 
   Payments on revolving line of credit      (176,000)     (9,000) 
   Proceeds from refinancing of long-term 
    debt                                      600,000     935,800 
   Payments relating to extinguishment and 
    modification of long-term debt                 --    (835,800) 
   Payments on long-term debt                 (10,561)     (4,679) 
   Payments of deferred financing costs        (4,040)         -- 
   Payment of contingent earnout 
    consideration up to amount of purchase 
    price accrual                                  --     (64,256) 
   Other financing activity                    (7,361)       (510) 
                                             --------    -------- 
      Net cash provided by financing 
       activities                             745,173     197,838 
                                             --------    -------- 
Net increase in cash and cash equivalents 
 and fiduciary cash                           263,791      70,933 
Cash and cash equivalents and fiduciary 
 cash at beginning of period                  346,897     312,769 
                                             --------    -------- 
Cash and cash equivalents and fiduciary 
 cash at end of period                      $ 610,688   $ 383,702 
                                             ========    ======== 
 

NON-GAAP FINANCIAL MEASURES

Adjusted EBITDA, adjusted EBITDA margin, organic revenue, organic revenue growth, adjusted net income, adjusted diluted earnings per share ("EPS"), and adjusted net cash provided by operating activities ("adjusted free cash flow") are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for organic revenue and organic revenue growth), net income (loss) (for adjusted EBITDA and adjusted EBITDA margin), net income (loss) attributable to Baldwin (for adjusted net income), diluted earnings (loss) per share (for adjusted diluted EPS) or net cash provided by (used in) operating activities (for adjusted free cash flow), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to Baldwin, diluted earnings (loss) per share, net cash provided by (used in) operating activities or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly, these measures may not be comparable to similarly titled measures used by other companies.

We define adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, transformation costs, severance, and certain non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance.

Adjusted EBITDA margin is adjusted EBITDA divided by total revenues. Adjusted EBITDA margin is a key metric used by management and our board of directors to assess our financial performance. We believe that adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance. We believe that adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.

Adjusted EBITDA and adjusted EBITDA margin have important limitations as analytical tools. For example, adjusted EBITDA and adjusted EBITDA margin:

   --  do not reflect any cash capital expenditure requirements for the assets 
      being depreciated and amortized that may have to be replaced in the 
      future; 
 
   --  do not reflect changes in, or cash requirements for, our working 
      capital needs; 
 
   --  do not reflect the impact of certain cash charges resulting from 
      matters we consider not to be indicative of our ongoing operations; 
 
   --  do not reflect the interest expense or the cash requirements necessary 
      to service interest or principal payments on our debt; 
 
   --  do not reflect share-based compensation expense and other non-cash 
      charges; and 
 
   --  exclude certain tax payments that may represent a reduction in cash 
      available to us. 

We calculate organic revenue based on commissions and fees for the relevant period by excluding (i) the first 12 months of commissions and fees generated from new partners and (ii) commissions and fees from divestitures. Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period because the relevant partners had not yet reached the 12-month owned mark, but which have reached the 12-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue. For example, commissions and fees from a partner acquired on June 1, 2025 are excluded from organic revenue for 2025. However, after June 1, 2026, results from June 1, 2025 to December 31, 2025 for such partners are compared to results from June 1, 2026 to December 31, 2026 for purposes of calculating organic revenue growth in 2026. Organic revenue growth is a key metric used by management and our board of directors to assess our financial performance. We believe that organic revenue and organic revenue growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.

We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related partnership and integration expenses, transformation costs, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.

Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.

We calculate adjusted free cash flow because we incur substantial earnout liabilities in conjunction with our partnership strategy. Adjusted free cash flow is calculated as net cash provided by (used in) operating activities excluding the impact of: (i) the payment of contingent earnout consideration in excess of purchase price accrual, and (ii) the payment of colleague earnout incentives. We believe that adjusted free cash flow is an important measure of our ability to generate cash from our business operations.

Reconciliation of guidance regarding adjusted EBITDA, organic revenue growth and adjusted diluted EPS to the most directly comparable GAAP measures is not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity, and low visibility with respect to commissions and fees, net income (loss), diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. The Company is currently unable to predict with a reasonable degree of certainty the type and extent of items that would be expected to impact these GAAP financial measures for these periods. The unavailable information could have a significant impact on the non-GAAP measures.

Adjusted EBITDA and Adjusted EBITDA Margin

The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net income (loss), which we consider to be the most directly comparable GAAP financial measure:

 
                             For the Three Months          For the Six Months 
                                Ended June 30,               Ended June 30, 
                          --------------------------  ---------------------------- 
(in thousands, except 
percentages)                  2026          2025           2026           2025 
                          ------------  ------------  --------------  ------------ 
Revenues                  $492,939      $378,811      $1,025,174      $792,216 
 
Net income (loss)         $(55,981)     $ (5,141)     $  (57,877)     $ 19,757 
Adjustments to net 
income (loss): 
   Amortization expense     56,027        26,010         111,074        51,892 
   Interest expense, 
    net(1)                  46,140        31,320          85,347        61,296 
   Share-based 
    compensation            20,701        16,952          33,519        29,755 
   Transaction-related 
    partnership and 
    integration 
    expenses                14,695         3,985          22,868         5,518 
   Transaction closing 
   costs                        --            --          17,668            -- 
   Change in fair value 
    of contingent 
    consideration           12,303        (1,957)         14,272         6,104 
   Income and other 
    taxes(2)                 1,084         1,348         (13,064)        2,819 
   Transformation 
    costs(3)                 6,441           227           9,500           772 
   Loss on 
    extinguishment and 
    modification of 
    debt                       129            --           7,538         2,394 
   Severance                 3,874         1,618           5,689         2,825 
   Depreciation expense      2,773         1,642           4,804         3,225 
   Colleague earnout 
    incentives                  --         1,490              --        (1,779) 
   Impairment of 
    right-of-use assets         --         1,188              --         1,188 
   Loss (gain) on 
    divestitures                --         1,111              --          (290) 
   Other(4)                  8,554         5,719          12,650        13,831 
                           -------       -------       ---------       ------- 
      Adjusted EBITDA     $116,740      $ 85,512      $  253,988      $199,307 
                           =======       =======       =========       ======= 
 
Net income (loss) margin       (11)%          (1)%            (6)%           2% 
Adjusted EBITDA margin        23.7%         22.6%           24.8%         25.2% 
 
 
____________________ 
(1)   Interest expense, net does not include interest income on surplus notes. 
(2)   Income and other taxes include income tax expense/benefit, Tax 
      Receivable Agreement expense and other operating tax expense, such as 
      state taxes, under GAAP. 
(3)   Transformation costs represent certain non-recurring colleague 
      compensation and technology-related expenses related to our $3B/30 
      Catalyst Program, which is designed to accelerate the infusion of 
      automation, business process optimization and artificial intelligence to 
      transform and elevate our workforce and unlock new avenues for growth. 
(4)   Other addbacks to adjusted EBITDA include certain income and expenses 
      that are considered to be non-recurring or non-operational, including 
      certain recruiting costs, professional fees, litigation costs and 
      bonuses. 
 

Organic Revenue and Organic Revenue Growth

The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:

 
                     For the Three Months           For the Six Months 
                         Ended June 30,               Ended June 30, 
                  ---------------------------  ---------------------------- 
(in thousands, 
except 
percentages)          2026           2025           2026           2025 
                  -------------  ------------  --------------  ------------ 
Commissions and 
 fees             $ 488,789      $376,249      $1,017,650      $786,780 
Partnership 
 commissions and 
 fees(1)           (106,755)       (1,980)       (218,240)       (1,980) 
                   --------       -------       ---------       ------- 
   Organic 
    revenue       $ 382,034      $374,269      $  799,410      $784,800 
                   ========       =======       =========       ======= 
Organic revenue 
 growth(2)        $   5,697      $ 37,973      $   12,630      $ 76,192 
Organic revenue 
 growth %(2)              2%           11%              2%           11% 
 
 
____________________ 
(1)   Includes the first 12 months of such commissions and fees generated from 
      newly acquired partners. 
(2)   Organic revenue for the three and six months ended June 30, 2025 used to 
      calculate organic revenue growth for the three and six months ended June 
      30, 2026 was $376.3 million and $786.8 million, respectively, which is 
      adjusted to exclude commissions and fees from divestitures that occurred 
      during 2025. 
 

Adjusted Net Income and Adjusted Diluted EPS

The following table reconciles adjusted net income to net income attributable to Baldwin and reconciles adjusted diluted EPS to diluted earnings (loss) per share, which we consider to be the most directly comparable GAAP financial measures:

 
                              For the Three Months    For the Six Months 
                                 Ended June 30,         Ended June 30, 
                              --------------------  ---------------------- 
(in thousands, except per 
share data)                     2026       2025       2026        2025 
                              ---------  ---------  ---------  ----------- 
Net income (loss) 
 attributable to Baldwin      $(38,995)  $ (3,164)  $(36,654)  $ 10,775 
   Net income (loss) 
    attributable to 
    noncontrolling 
    interests                  (16,986)    (1,977)   (21,223)     8,982 
   Amortization expense         56,027     26,010    111,074     51,892 
   Share-based compensation     20,701     16,952     33,519     29,755 
   Transaction-related 
    partnership and 
    integration expenses        14,695      3,985     22,868      5,518 
   Transaction closing 
   costs                            --         --     17,668         -- 
   Change in fair value of 
    contingent 
    consideration               12,303     (1,957)    14,272      6,104 
   Income tax expense(1)            84        685    (14,110)     1,885 
   Transformation costs(2)       6,441        227      9,500        772 
   Loss on extinguishment 
    and modification of 
    debt                           129         --      7,538      2,394 
   Other 
    amortization/accretion, 
    net                          6,406      1,421      7,509      2,843 
   Severance                     3,874      1,618      5,689      2,825 
   Depreciation                  2,773      1,642      4,804      3,225 
   Colleague earnout 
    incentives                      --      1,490         --     (1,779) 
   Impairment of 
    right-of-use assets             --      1,188         --      1,188 
   Loss (gain) on 
    divestitures                    --      1,111         --       (290) 
   Other(3)                      8,554      5,719     12,650     13,831 
                               -------    -------    -------    ------- 
Adjusted pre-tax income         76,006     54,950    175,104    139,920 
   Adjusted income taxes(4)      7,524      5,440     17,335     13,852 
                               -------    -------    -------    ------- 
Adjusted net income           $ 68,482   $ 49,510   $157,769   $126,068 
                               =======    =======    =======    ======= 
 
Weighted-average shares of 
 Class A common stock 
 outstanding - diluted          92,761     68,010     93,278     70,393 
   Dilutive weighted-average 
    shares of Class A common 
    stock                        4,189      3,436      3,614         -- 
   Exchange of Class B 
    common stock(5)             44,373     47,717     45,163     48,377 
                               -------    -------    -------    ------- 
Adjusted diluted 
 weighted-average shares 
 outstanding                   141,323    119,163    142,055    118,770 
                               =======    =======    =======    ======= 
 
Diluted earnings (loss) per 
 share                        $  (0.42)  $  (0.05)  $  (0.39)  $   0.15 
   Effect of exchange of 
    Class B common stock and 
    net income (loss) 
    attributable to 
    noncontrolling interests 
    per share                     0.02       0.01      (0.02)      0.02 
   Other adjustments to 
    earnings (loss) per 
    share                         0.93       0.51       1.64       1.01 
   Adjusted income taxes per 
    share                        (0.05)     (0.05)     (0.12)     (0.12) 
                               -------    -------    -------    ------- 
Adjusted diluted EPS          $   0.48   $   0.42   $   1.11   $   1.06 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10